wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414487-5436519E-D6A0-4B61-939B-4C59C7C5D7AE
Q33414487-5436519E-D6A0-4B61-939B-4C59C7C5D7AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-5436519E-D6A0-4B61-939B-4C59C7C5D7AE
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
P2860
Q33414487-5436519E-D6A0-4B61-939B-4C59C7C5D7AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-5436519E-D6A0-4B61-939B-4C59C7C5D7AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e0740ce3437f0267556f313ae424ed20fe9be62
P2860
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.